Informações:
Falhas:
ID
23239
Descrição
Duloxetine for Perimenopausal Depression; ODM derived from: https://clinicaltrials.gov/show/NCT00517985
Link
https://clinicaltrials.gov/show/NCT00517985
Palavras-chave
Versões (1)
- 30/06/2017 30/06/2017 -
Transferido a
30 de junho de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Major Depressive Disorder NCT00517985
Eligibility Major Depressive Disorder NCT00517985
- StudyEvent: Eligibility
Similar models
Eligibility Major Depressive Disorder NCT00517985
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
women age 40 years old or older.
boolean
C0001779 (UMLS CUI [1])
ID.2
Item
perimenopausal symptoms of at least 3 months duration, including irregular periods and/or hot flashes.
boolean
C3839366 (UMLS CUI [1])
ID.3
Item
minimum score of 15 on the hamilton rating scale for depression (17-item).
boolean
C0451203 (UMLS CUI [1])
ID.4
Item
subjects must be able to be treated on an outpatient basis.
boolean
C0199298 (UMLS CUI [1])
ID.5
Item
subjects must be able to provide written informed consent.
boolean
C0021430 (UMLS CUI [1])
ID.6
Item
subjects presently taking antidepressant medication.
boolean
C0003289 (UMLS CUI [1])
ID.7
Item
subjects currently using hormone replacement therapy.
boolean
C0019930 (UMLS CUI [1])
ID.8
Item
subjects who are pregnant.
boolean
C0032961 (UMLS CUI [1])
ID.9
Item
subjects who have hepatic disease.
boolean
C0023895 (UMLS CUI [1])
ID.10
Item
other axis i disorders, except generalized anxiety disorder or panic disorder.
boolean
C0270287 (UMLS CUI [1])
ID.11
Item
"uncontrolled" narrow angle glaucoma.
boolean
C0017605 (UMLS CUI [1])
ID.12
Item
known hypersensitivity to duloxetine or any of the inactive ingredients.
boolean
C0245561 (UMLS CUI [1,1])
C0020517 (UMLS CUI [1,2])
C0020517 (UMLS CUI [1,2])
ID.13
Item
treatment with a monoamine oxidase inhibitor (maoi) within 14 days of study drug administration or potential need to use an maoi during the study or within 5 days of discontinuation of study drug.
boolean
C0026457 (UMLS CUI [1])
ID.14
Item
presence of psychotic symptoms.
boolean
C0871189 (UMLS CUI [1])
ID.15
Item
history of mania or hypomania.
boolean
C0024713 (UMLS CUI [1,1])
C0241934 (UMLS CUI [1,2])
C0241934 (UMLS CUI [1,2])
ID.16
Item
hamilton rating scale for depression (ham-d) suicide item score > 2.
boolean
C0451203 (UMLS CUI [1])
ID.17
Item
end stage renal disease or severe renal impairment.
boolean
C0022658 (UMLS CUI [1])
ID.18
Item
abnormal uterine bleeding that has not been evaluated by a gynecologist (heavy or prolonged uterine bleeding, menstrual periods occurring more frequently than every 3 weeks, bleeding after sexual intercourse, spotting between periods).
boolean
C3650625 (UMLS CUI [1])